Back To: Home




September 18-19, 2014

September 18, 2014

More Events
Name:
Company:
Email:
 
 
 

Improved pharmacokinetics in human antibody therapeutics
April 2012
SHARING OPTIONS:

arGEN-X
 
NHance by arGEN-X enables researchers to create truly differentiated human antibody therapeutics, prolonging the circulation time of therapeutic antibodies in the body thanks to engineering of the antibody constant region (Fc). The technology offers superior pharmacokinetics without impairment of Fc-mediated cell-killing effects, and enables reduced antibody dosing as well as improvements to efficacy and patient convenience.
 
arGEN-X
+31 (0) 10 70 38 441


Back








CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2014 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.